US STOCK
ABT Stock Analysis
US stocks · market data · technical indicators
Abbott Laboratories
ABTUS stocksQuote delayed 15 min
9/11 下午02:30 updated
$103.36
-1.87-1.78%
Open
$105.18
High
$105.19
Low
$103.18
Volume
784.48萬
ABT price history
-7.11%Open
111.27
Latest
103.36
High
116.67
Low
103.36
Average
111.14
Advertisement
AI Composite Technical Analysis
BetaFormula: fundamentals (40%) + technical indicators (30%) + market sentiment (30%)
AI Score50
Score range 0–100; a higher score indicates a stronger buy signal
Market Status
HoldCurrent Price$103.36
Target Price$103.36
Change %-1.78%
Institutional
Flat
Foreign Ownership
Flat
Market Heat
Cautious
Fundamentals (US)
P/E Ratio
32.96x
ROE
10.58%
P/B Ratio
3.45x
Dividend Yield
2.44%
Market Insight
The score sits in neutral territory (50/100). Waiting for a clearer signal may be warranted.
This analysis is for reference only and does not constitute investment advice. Investing carries risk; educational content only.
Financial snapshot
ABT - Abbott Laboratories
EPS
3.09USD
Forward EPS
6.06USD
P/E
32.96x
Forward P/E
16.79x
P/B
3.45x
ROE
10.58%
ROA
5.33%
Operating margin
14.71%
Profit margin
11.65%
Revenue growth
13.00%
Earnings growth
-47.50%
Dividend yield
2.44%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | — | $11.16B | $11.46B | $11.37B | $11.14B | $10.36B |
| Gross profit | — | $6.27B | $6.54B | $6.29B | $6.29B | $5.89B |
| Operating income | — | $1.34B | $2.25B | $2.06B | $2.05B | $1.69B |
| Net income | — | $1.08B | $1.78B | $1.64B | $1.78B | $1.32B |
| Basic EPS | 0.53 | 0.62 | 1.02 | 0.95 | 1.02 | — |
| Diluted EPS | 0.53 | 0.61 | 1.01 | 0.94 | 1.01 | — |
Estimates vs actuals
Next earnings
2026-10-14
EPS estimate
1.42
Revenue estimate
$12.99B
Last surprise
+2.61%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-14 | 1.42 | Not reported | — |
| 2026-07-16 | 1.28 | 1.31 | +2.61% |
| 2026-04-16 | 1.15 | 1.15 | +0.33% |
| 2026-01-22 | 1.49 | 1.50 | +0.34% |
| 2025-10-15 | 1.30 | 1.30 | +0.05% |
| 2025-07-17 | 1.26 | 1.26 | +0.28% |
| 2025-04-16 | 1.07 | 1.09 | +1.74% |
| 2025-01-22 | 1.34 | 1.34 | -0.17% |
| 2024-10-16 | 1.20 | 1.21 | +0.76% |
| 2024-07-18 | 1.10 | 1.14 | +3.17% |
| 2024-04-17 | 0.95 | 0.98 | +2.81% |
| 2024-01-24 | 1.19 | 1.19 | +0.04% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $22B | 0.32% |
| BlackRock Inc. | 2024-06-30 | $13.6B | 0.31% |
| STATE STREET CORP | 2026-06-30 | $7.3B | 0.22% |
| CITADEL ADVISORS LLC | 2026-06-30 | $780.1M | 0.09% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $737.4M | 0.53% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $62.3M | 0.09% |
| Bridgewater Associates, LP | 2026-06-30 | $5.4M | 0.02% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$120.21
Target range
$103.00 – $135.00
Implied upside
18.02%
Strong buy
4
Buy
17
Hold
5
Sell
0
Strong sell
0
Dividends
Annual yield
2.40%
Frequency
Quarterly
Recent payouts
- 2026-07-15$0.6300
- 2026-04-15$0.6300
- 2026-01-15$0.6300
- 2025-10-15$0.5900
Advertisement